The CRISPR genomic cure market is estimated to be valued at US$ 1.84 billion in 2023 and is expected to exhibit a CAGR of 34.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and the Cas system is a bacterial genome-editing tool that can cure genetic diseases by precisely editing genes. CRISPR technology allows precise and permanent ... Read more
